Nonpharmacokinetic Clinical Factors Affecting Aminoglycoside Therapeutic Precision
- 9 Downloads
A Monte Carlo simulation study evaluated the effects of a simulated ‘good’ or ‘poor’ ward care setting, pharmacy, laboratory and phlebotomy service on the resulting precision of control of serum tobramycin concentrations in a representative (theoretical) patient receiving the drug. The ward care (precise dose administration and recording of times given) and the pharmacy (precise dosage preparation) played significant roles in achieving precise serum concentrations whereas laboratory (assay precision) and the phlebotomy service (precise labelling of blood specimen times) were considerably less important. However, use of a simulated ‘smart’ infusion pump contributed most to therapeutic precision.
These results suggest that therapeutic precision can be increased, and costs reduced, by manufacturing total daily drug doses in reproducible concentrations in conveniently sized bags and tubing, minimising preparation of individual doses (saving labour costs), and administering each individual dose from the bag precisely, either with conventional accurately set infusion pumps or with ‘smart’ infusion apparatus.
KeywordsPharmacokinetic Model Drug Invest Simulated Patient Ward Care Serum Concentration Data
Unable to display preview. Download preview PDF.
- Beckmann P. A history of pi, 3rd ed., pp. 163–165, St Martin’s Press, New York, 1974Google Scholar
- Box GEP, Lucas HL. Design of experiments in nonlinear situations. Biometrika 46: 77–90, 1959Google Scholar
- Iles D, Schumitzky A. Multiple model adaptive control of pharmacokinetic systems. Technical Report 84–1, Laboratory of Applied Pharmacokinetics, University of Southern California School of Medicine, 1984Google Scholar
- Jazwinski A. Stochastic processes and filtering theory. Academic Press, New York, 1970Google Scholar
- Jelliffe RW. Clinical applications of pharmacokinetics and control theory. In Maronde (Ed.) Topics in clinical pharmacology and therapeutics, pp. 57–80, Springer-Verlag, New York, 1986Google Scholar
- Jelliffe R. Explicit determination of laboratory assay errors — a useful aid in therapeutic drug monitoring. ASCP Drug Monitoring and Toxicology Check Sample, Vol. 10, pp. 1–5, No. DM 89–4 (DM-56). American Society of Clinical Pathologists, Chicago, Illinois, 1989Google Scholar
- Jelliffe R, Nicholson W. Computer-assisted therapy and automated infusion apparatus. In Fokkens et al. (Eds) Proceedings of the Medinfo — 83 Seminars, pp. 126–128, IFIP-IMIA, North Holland, 1983Google Scholar
- Jelliffe R, Rodman J, Kolb E. Clinical studies with computerassisted lidocaine infusion regimens. Proceedings of the 10th Inter-American Congress of Cardiology, Caracas, Venezuela, September 5–11, 1976Google Scholar
- Jelliffe RW, Schumitzky A, D’Argenio DZ, Katz D, Nicholson WF, et al. Time-shared computer programs for MAP Bayesian forecasting and adaptive control of dosage regimens of lidocaine, aminoglycosides, procainamide, digoxin, digitoxin, and quinidine, with optimal monitoring strategies and automatic delivery of infusion protocols. Proceedings of the 2nd World Congress on Clinical Pharmacology and Therapeutics, Washington DC, July 31-August 5, p. 46, 1983Google Scholar
- Jelliffe RW, D’Argenio DZ, Schumitzky A, Hu L, Liu M. The USC PC-PACK programs for planning, monitoring, and adjusting drug dosage regimens. Proceedings of the 23rd Annual Meeting of the Association for the Advancement of Medical Instrumentation, Washington, DC, p. 51 (available from the first author through a non-commercial licence agreement with the University of Southern California, May 14–18, 1988)Google Scholar
- Jelliffe R, Iglesias T, Hurst A, Foo K, Rodriguez J. Individualizing drug dosage regimens: a review, with comparison of two types of pharmacokinetic models of gentamicin, three methods of fitting serum concentration data, and D-optimal versus conventional monitoring strategies. Clinical Pharmacokinetics 21: 461–478, 1991PubMedCrossRefGoogle Scholar
- Landaw E. Optimal design for individual parameter estimation in pharmacokinetics. In Rowland et al. (Eds) Variation in drug therapy: description, estimation and control, pp. 187–200, Raven Press, New York, 1985Google Scholar
- Maire P, Jelliffe R, Dumarest C, Roux D, Breant V, et al. Controle adaptatif optimal des posologies: experience des aminosides en geriatrie. In Venot & Degoulet (Eds) Informatique et Sante, Vol. 2, informatique et medicaments, comptes rendus du colloque AIM-IF et IRT, Paris, December, 1989, pp. 154–169, Springer Verlag, Paris, 1989Google Scholar
- Rodman J. Unpublished data, personal communication, 1982Google Scholar
- Steimer JL, Mallet A, Mentre F. Estimating interindividual pharmacokinetic variability. In Rowland et al. (Eds) Variability in drug therapy: description, estimation, and control, pp. 65–111, Raven Press, New York, 1985Google Scholar
- Ulam S. Adventures of a mathematician, pp. 196–200, Charles Scribner’s Sons, New York, 1983Google Scholar